Global Photodynamic Therapy Market By Offerings (Drugs (Porfimer Sodium, Methyl Ester of Aminolevulinic Acid (ALA), Aminolevulinic Acid (ALA) and Others), Devices (Laser, Non-Laser)); By Application (Cancer (Lung, Esophagus, Bile Duct, Bladder, Brain, Ovarian and Others), Psoriasis, Acne, Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy (PCV), Others); By End-User (Hospitals, Cancer Treatment Centers, Skin Clinics, Others); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
The concept of cell death being achievable by the interaction of light as well as chemicals has been practiced for over 100 years. It was first reported by Oscar Raab, in 1900. Photodynamic therapy (PDT) is carried out via a photochemical reaction between a light activatable molecule or photosensitizer (PS) light, which is usually in the visible spectrum along with molecular oxygen. With the combination of a light activated drug and visible/near-infrared light, photodynamic therapy proves to be a promising modality in treating cancerous cells and other non-life threating conditions. The light activated drug is known as the photosensitizer, which induces very less toxic effects. Photosensitizers absorbs the light and changes it into another form, resulting in destroying cancer cells. The photodynamic therapy (PDT) market is mainly dominated by the sales of photosensitizer drugs. As seen in drug development, there are many market participants that are increasing the complexity of drug molecules with an aim to prevent them from being replicated by competitors. Similarly, in this market space, there are various players that are offering treatment avenues via ground-breaking routes to the market with the launch of combinational products that involve a photosensitizer drug and a device. Additionally, with the rising R&D investment by the market participants to discover new photosensitizers so as to improve clinical outcomes is further expected to boost the global photodynamic therapy market growth over the forecast period.
Photodynamic therapy is considered to be one of the safest procedures to battle against viral infections. Due to humongous spread of COVID-19, researchers are continuously developing new therapies and treatments. Some of them have presented promising outcomes in clinical trials and have been approved for clinical applications to combat SARS-CoV-2. Furthermore, a recent study recommended that PDT is as an alternative therapy for SARS-CoV-2 infection in 2020, however there is still ongoing research that is being carried out. Thus, with COVID-19 pandemic, the photodynamic therapy market is gaining more traction.
In terms of revenue, global photodynamic therapy market was valued at US$ 4872.9 Mn in 2020 and is anticipated to reach US$ 18261.8 Mn by 2029 growing at a CAGR of 15.89% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Photodynamic Therapy Market Revenue & Forecast (US$ Million), 2015-2029
Offerings Outlook
Photodynamic drugs remain a promising alternative to conventional treatments for cancer in their early stages. For example, PDT has proven to a promising therapy in treating patients with 85% response rates in treating lung cancer. These patients were deemed unsuitable for surgery as the cancer was in its early stage, and surgery remains an expensive, and invasive affair, resulting in tremendous potential fallout from rising elderly population of patients. Moreover, PDT therapy is also undergoing a tremendous scrutiny from researchers, resulting in promising opportunities for new players. Rising efficacy of drug therapy, due to growing research in solutions like porfimer sodium, and aminolaevulinic acid present new horizons for growth for players in the global photodynamic therapy market. Growing research shows that the hypoxic status of tumors can be improved tremendously by using novel nonreactive oxygen carriers such as perfluorocarbon carbide. These have shown their commercial promise in practice, and are used in combination with oxygen supply materials like hydrogen peroxide enzymes, and metal oxides. These active nanoparticles assist in production of oxygen under PDT conditions and take greater advantage of laser-based therapy to fight off cancerous cell growth. Furthermore, hypoxia-inducible factor inhibitors in the therapy can be used to target organelles, which can increase blood perfusion, and also deliver new, and combined therapies for patients. The therapy is proven to result in zero long-term side effects, and remains far more cost-effective as compared to conventional cancer therapies. Furthermore, in areas like skin cancer treatments, the conventional forms of therapy can be less effective, and result in damage to the skin, wherein the photodynamic therapy remains the safest alternative.
Application Outlook
Based on applications, cancer treatment segment accounted for the highest market share in 2020, in the global photodynamic therapy market. Cancer is regarded as a worldwide health problem, thus being declared as a disease with the highest impact cross the globe creating a rising need to address this concern. Photodynamic therapy presents reduced long-term morbidity when compared to chemotherapy or radiotherapy, appearing as a promising alternative treatment for controlling malignant diseases. This therapy is used to treat various conditions including pancreatic cancer, Bile duct cancer (cholangiocarcinoma), Esophageal cancer, certain skin diseases, including precancerous skin changes (actinic keratosis) and nonmelanoma skin cancer and lung cancer amongst others.
Region Outlook
Based on regions, North America region accounted for the major share in the global photodynamic therapy market in 2020, owing to high number of cancer cases and a well-established healthcare infrastructure along with the presence of key market players in this region. However, Asia Pacific is expected to be the fastest growing region in the photodynamic therapy market over the forecast period (2021-2029).
Competitive Landscape
The report provides both, qualitative and quantitative research of global photodynamic therapy market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global photodynamic therapy market are Bausch & Lomb, Biofrontera Inc., biolitec AG, Galderma Nordic AB, MODULIGHT, Quantel Medical, Quest PharmaTech Inc., Soligenix, Sun Pharma, Theralase Technologies Inc. and Other market participants
Photodynamic Therapy Market
- By Offering
- Drugs
- Porfimer Sodium
- Methyl Ester of Aminolevulinic Acid (ALA)
- Aminolevulinic Acid (ALA)
- Others
- Devices
- Laser
- Non-Laser
- Drugs
- By Application
- Cancer
- Lung
- Esophagus
- Bile Duct
- Bladder
- Brain
- Ovarian
- Others
- Psoriasis
- Acne
- Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy (PCV)
- Others
- Cancer
- By End-Users
- Hospitals
- Cancer Treatment Centers
- Skin Clinics
- Others
- By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015- 2018
1.2.2. Base
Year: 2019
1.2.3. Forecast
Years: 2020 – 2028
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Photodynamic Therapy Market
6. Market Synopsis:
Photodynamic Therapy Market
7. Photodynamic Therapy Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Photodynamic Therapy Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators: Photodynamic
Therapy Market
7.6. Porter’s Five Force Analysis
7.7. Impact of COVID-19 on Photodynamic Therapy Market
8. Global Photodynamic Therapy Market Analysis and Forecasts,
2020 – 2028
8.1. Overview
8.1.1. Global
Photodynamic Therapy Market Revenue (US$ Mn)
8.2. Global
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
8.2.1. Drugs (Definition, Market Estimation and
Penetration, 2015 - 2019, Market Estimation (2015 - 2019), Market Forecast
(2020 – 2028), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Porfimer Sodium, Methyl Ester of Aminolevulinic Acid (ALA),
Aminolevulinic Acid (ALA), Others)
8.2.1.1. Porfimer
Sodium
8.2.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
8.2.1.3. Aminolevulinic
Acid (ALA)
8.2.1.4. Others
8.2.2. Devices
(Definition, Market Estimation and Penetration, 2015 - 2019, Market Estimation
(2015 - 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Laser, Non-Laser)
8.2.2.1. Laser
8.2.2.2. Non-Laser
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offering
9. Global Photodynamic Therapy Market Analysis and Forecasts,
2020 – 2028
9.1. Overview
9.2. Global
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Cancer (Definition,
Market Estimation and Penetration, 2015 - 2019, Market Estimation (2015 -
2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate (CAGR),
Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and
Africa, Latin America) and Information on Lung, Esophagus, Bile Duct, Bladder,
Brain, Ovarian, Others)
9.2.1.1. Lung
9.2.1.2. Esophagus
9.2.1.3. Bile
Duct
9.2.1.4. Bladder
9.2.1.5. Brain
9.2.1.6. Ovarian
9.2.1.7. Others
9.2.2. Psoriasis
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 - 2019
9.2.2.3. Market
Forecast, 2020 – 2028
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2019
9.2.2.5.1.2. Market
Forecast, 2020 – 2028
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2019
9.2.2.5.2.2. Market
Forecast, 2020 – 2028
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2019
9.2.2.5.3.2. Market
Forecast, 2020 – 2028
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2019
9.2.2.5.4.2. Market
Forecast, 2020 – 2028
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2019
9.2.2.5.5.2. Market
Forecast, 2020 – 2028
9.2.3. Acne
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 - 2019
9.2.3.3. Market
Forecast, 2020 – 2028
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2019
9.2.3.5.1.2. Market
Forecast, 2020 – 2028
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2019
9.2.3.5.2.2. Market
Forecast, 2020 – 2028
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2019
9.2.3.5.3.2. Market
Forecast, 2020 – 2028
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2019
9.2.3.5.4.2. Market
Forecast, 2020 – 2028
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2019
9.2.3.5.5.2. Market
Forecast, 2020 – 2028
9.2.4. Central
Serous Retinopathy/Polypoidal Choroidal Vasculopathy (PCV)
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 - 2019
9.2.4.3. Market
Forecast, 2020 – 2028
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2019
9.2.4.5.1.2. Market
Forecast, 2020 – 2028
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2019
9.2.4.5.2.2. Market
Forecast, 2020 – 2028
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2019
9.2.4.5.3.2. Market
Forecast, 2020 – 2028
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2019
9.2.4.5.4.2. Market
Forecast, 2020 – 2028
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2019
9.2.4.5.5.2. Market
Forecast, 2020 – 2028
9.2.5. Others
9.2.5.1. Definition
9.2.5.2. Market
Estimation and Penetration, 2015 - 2019
9.2.5.3. Market
Forecast, 2020 – 2028
9.2.5.4. Compound
Annual Growth Rate (CAGR)
9.2.5.5. Regional
Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market
Estimation, 2015 - 2019
9.2.5.5.1.2. Market
Forecast, 2020 – 2028
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2019
9.2.5.5.2.2. Market
Forecast, 2020 – 2028
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2019
9.2.5.5.3.2. Market
Forecast, 2020 – 2028
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2019
9.2.5.5.4.2. Market
Forecast, 2020 – 2028
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market
Estimation, 2015 - 2019
9.2.5.5.5.2. Market
Forecast, 2020 – 2028
9.3. Key
Segment for Channeling Investments
9.3.1. By
Application
10. Global Photodynamic Therapy Market Analysis and Forecasts,
2020 – 2028
10.1. Overview
10.2. Global
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
10.2.1. Hospitals
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 - 2019
10.2.1.3. Market
Forecast, 2020 – 2028
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2019
10.2.1.5.1.2. Market
Forecast, 2020 – 2028
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2019
10.2.1.5.2.2. Market
Forecast, 2020 – 2028
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2019
10.2.1.5.3.2. Market
Forecast, 2020 – 2028
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2019
10.2.1.5.4.2. Market
Forecast, 2020 – 2028
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2019
10.2.1.5.5.2. Market
Forecast, 2020 – 2028
10.2.2. Cancer
Treatment Centers
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 - 2019
10.2.2.3. Market
Forecast, 2020 – 2028
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2019
10.2.2.5.1.2. Market
Forecast, 2020 – 2028
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2019
10.2.2.5.2.2. Market
Forecast, 2020 – 2028
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2019
10.2.2.5.3.2. Market
Forecast, 2020 – 2028
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2019
10.2.2.5.4.2. Market
Forecast, 2020 – 2028
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2019
10.2.2.5.5.2. Market
Forecast, 2020 – 2028
10.2.3. Skin
Clinics
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 - 2019
10.2.3.3. Market
Forecast, 2020 – 2028
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2019
10.2.3.5.1.2. Market
Forecast, 2020 – 2028
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2019
10.2.3.5.2.2. Market
Forecast, 2020 – 2028
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2019
10.2.3.5.3.2. Market
Forecast, 2020 – 2028
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2019
10.2.3.5.4.2. Market
Forecast, 2020 – 2028
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2019
10.2.3.5.5.2. Market
Forecast, 2020 – 2028
10.2.4. Others
10.2.4.1. Definition
10.2.4.2. Market
Estimation and Penetration, 2015 - 2019
10.2.4.3. Market
Forecast, 2020 – 2028
10.2.4.4. Compound
Annual Growth Rate (CAGR)
10.2.4.5. Regional
Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2019
10.2.4.5.1.2. Market
Forecast, 2020 – 2028
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2019
10.2.4.5.2.2. Market
Forecast, 2020 – 2028
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2019
10.2.4.5.3.2. Market
Forecast, 2020 – 2028
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2019
10.2.4.5.4.2. Market
Forecast, 2020 – 2028
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2019
10.2.4.5.5.2. Market
Forecast, 2020 – 2028
10.3. Key
Segment for Channeling Investments
10.3.1. By
End-Users
11. North America Photodynamic Therapy Market Analysis and
Forecasts, 2020 - 2028
11.1. Overview
11.1.1. North
America Photodynamic Therapy Market Revenue (US$ Mn)
11.2. North
America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
11.2.1. Drugs
11.2.1.1. Porfimer
Sodium
11.2.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
11.2.1.3. Aminolevulinic
Acid (ALA)
11.2.1.4. Others
11.2.2. Devices
11.2.2.1. Laser
11.2.2.2. Non-Laser
11.3. North
America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
11.3.1. Cancer
11.3.1.1. Lung
11.3.1.2. Esophagus
11.3.1.3. Bile
Duct
11.3.1.4. Bladder
11.3.1.5. Brain
11.3.1.6. Ovarian
11.3.1.7. Others
11.3.2. Psoriasis
11.3.3. Acne
11.3.4. Central
Serous Retinopathy/Polypoidal Choroidal Vasculopathy (PCV)
11.3.5. Others
11.4. North America
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
11.4.1. Hospitals
11.4.2. Cancer
Treatment Centers
11.4.3. Skin
Clinics
11.4.4. Others
11.5. North
America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
11.5.1.1.1. Drugs
11.5.1.1.1.1. Porfimer
Sodium
11.5.1.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
11.5.1.1.1.3. Aminolevulinic
Acid (ALA)
11.5.1.1.1.4. Others
11.5.1.1.2. Devices
11.5.1.1.2.1. Laser
11.5.1.1.2.2. Non-Laser
11.5.1.2. U.S
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
11.5.1.2.1. Cancer
11.5.1.2.1.1. Lung
11.5.1.2.1.2. Esophagus
11.5.1.2.1.3. Bile
Duct
11.5.1.2.1.4. Bladder
11.5.1.2.1.5. Brain
11.5.1.2.1.6. Ovarian
11.5.1.2.1.7. Others
11.5.1.2.2. Psoriasis
11.5.1.2.3. Acne
11.5.1.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
11.5.1.2.5. Others
11.5.1.3. U.S
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
11.5.1.3.1. Hospitals
11.5.1.3.2. Cancer Treatment Centers
11.5.1.3.3. Skin Clinics
11.5.1.3.4. Others
11.5.2. Canada
11.5.2.1. Canada
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
11.5.2.1.1. Drugs
11.5.2.1.1.1. Porfimer
Sodium
11.5.2.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
11.5.2.1.1.3. Aminolevulinic
Acid (ALA)
11.5.2.1.1.4. Others
11.5.2.1.2. Devices
11.5.2.1.2.1. Laser
11.5.2.1.2.2. Non-Laser
11.5.2.2. Canada
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
11.5.2.2.1. Cancer
11.5.2.2.1.1. Lung
11.5.2.2.1.2. Esophagus
11.5.2.2.1.3. Bile
Duct
11.5.2.2.1.4. Bladder
11.5.2.2.1.5. Brain
11.5.2.2.1.6. Ovarian
11.5.2.2.1.7. Others
11.5.2.2.2. Psoriasis
11.5.2.2.3. Acne
11.5.2.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
11.5.2.2.5. Others
11.5.2.3. Canada
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
11.5.2.3.1. Hospitals
11.5.2.3.2. Cancer Treatment Centers
11.5.2.3.3. Skin Clinics
11.5.2.3.4. Others
11.5.3. Mexico
11.5.3.1. Mexico
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
11.5.3.1.1. Drugs
11.5.3.1.1.1. Porfimer
Sodium
11.5.3.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
11.5.3.1.1.3. Aminolevulinic
Acid (ALA)
11.5.3.1.1.4. Others
11.5.3.1.2. Devices
11.5.3.1.2.1. Laser
11.5.3.1.2.2. Non-Laser
11.5.3.2. Mexico
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
11.5.3.2.1. Cancer
11.5.3.2.1.1. Lung
11.5.3.2.1.2. Esophagus
11.5.3.2.1.3. Bile
Duct
11.5.3.2.1.4. Bladder
11.5.3.2.1.5. Brain
11.5.3.2.1.6. Ovarian
11.5.3.2.1.7. Others
11.5.3.2.2. Psoriasis
11.5.3.2.3. Acne
11.5.3.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
11.5.3.2.5. Others
11.5.3.3. Mexico
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
11.5.3.3.1. Hospitals
11.5.3.3.2. Cancer Treatment Centers
11.5.3.3.3. Skin Clinics
11.5.3.3.4. Others
11.5.4. Rest of
North America
11.5.4.1. Rest
of North America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Offering
11.5.4.1.1. Drugs
11.5.4.1.1.1. Porfimer
Sodium
11.5.4.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
11.5.4.1.1.3. Aminolevulinic
Acid (ALA)
11.5.4.1.1.4. Others
11.5.4.1.2. Devices
11.5.4.1.2.1. Laser
11.5.4.1.2.2. Non-Laser
11.5.4.2. Rest
of North America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
11.5.4.2.1. Cancer
11.5.4.2.1.1. Lung
11.5.4.2.1.2. Esophagus
11.5.4.2.1.3. Bile
Duct
11.5.4.2.1.4. Bladder
11.5.4.2.1.5. Brain
11.5.4.2.1.6. Ovarian
11.5.4.2.1.7. Others
11.5.4.2.2. Psoriasis
11.5.4.2.3. Acne
11.5.4.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
11.5.4.2.5. Others
11.5.4.3. Rest
of North America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
End-Users
11.5.4.3.1. Hospitals
11.5.4.3.2. Cancer Treatment Centers
11.5.4.3.3. Skin Clinics
11.5.4.3.4. Others
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Offering
11.6.3. By
Application
11.6.4. By
End-Users
12. Europe Photodynamic Therapy Market Analysis and Forecasts,
2020 - 2028
12.1. Overview
12.1.1. Europe
Photodynamic Therapy Market Revenue (US$ Mn)
12.2. Europe
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
12.2.1. Drugs
12.2.1.1. Porfimer
Sodium
12.2.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
12.2.1.3. Aminolevulinic
Acid (ALA)
12.2.1.4. Others
12.2.2. Devices
12.2.2.1. Laser
12.2.2.2. Non-Laser
12.3. Europe
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
12.3.1. Cancer
12.3.1.1. Lung
12.3.1.2. Esophagus
12.3.1.3. Bile
Duct
12.3.1.4. Bladder
12.3.1.5. Brain
12.3.1.6. Ovarian
12.3.1.7. Others
12.3.2. Psoriasis
12.3.3. Acne
12.3.4. Central
Serous Retinopathy/Polypoidal Choroidal Vasculopathy (PCV)
12.3.5. Others
12.4. Europe Photodynamic
Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
12.4.1. Hospitals
12.4.2. Cancer
Treatment Centers
12.4.3. Skin
Clinics
12.4.4. Others
12.5. Europe
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.1.1.1. Drugs
12.5.1.1.1.1. Porfimer
Sodium
12.5.1.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
12.5.1.1.1.3. Aminolevulinic
Acid (ALA)
12.5.1.1.1.4. Others
12.5.1.1.2. Devices
12.5.1.1.2.1. Laser
12.5.1.1.2.2. Non-Laser
12.5.1.2. France
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
12.5.1.2.1. Cancer
12.5.1.2.1.1. Lung
12.5.1.2.1.2. Esophagus
12.5.1.2.1.3. Bile
Duct
12.5.1.2.1.4. Bladder
12.5.1.2.1.5. Brain
12.5.1.2.1.6. Ovarian
12.5.1.2.1.7. Others
12.5.1.2.2. Psoriasis
12.5.1.2.3. Acne
12.5.1.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
12.5.1.2.5. Others
12.5.1.3. France
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
12.5.1.3.1. Hospitals
12.5.1.3.2. Cancer Treatment Centers
12.5.1.3.3. Skin Clinics
12.5.1.3.4. Others
12.5.2. The UK
12.5.2.1. The
UK Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.2.1.1. Drugs
12.5.2.1.1.1. Porfimer
Sodium
12.5.2.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
12.5.2.1.1.3. Aminolevulinic
Acid (ALA)
12.5.2.1.1.4. Others
12.5.2.1.2. Devices
12.5.2.1.2.1. Laser
12.5.2.1.2.2. Non-Laser
12.5.2.2. The
UK Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
12.5.2.2.1. Cancer
12.5.2.2.1.1. Lung
12.5.2.2.1.2. Esophagus
12.5.2.2.1.3. Bile
Duct
12.5.2.2.1.4. Bladder
12.5.2.2.1.5. Brain
12.5.2.2.1.6. Ovarian
12.5.2.2.1.7. Others
12.5.2.2.2. Psoriasis
12.5.2.2.3. Acne
12.5.2.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
12.5.2.2.5. Others
12.5.2.3. The
UK Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
12.5.2.3.1. Hospitals
12.5.2.3.2. Cancer Treatment Centers
12.5.2.3.3. Skin Clinics
12.5.2.3.4. Others
12.5.3. Spain
12.5.3.1. Spain
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.3.1.1. Drugs
12.5.3.1.1.1. Porfimer
Sodium
12.5.3.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
12.5.3.1.1.3. Aminolevulinic
Acid (ALA)
12.5.3.1.1.4. Others
12.5.3.1.2. Devices
12.5.3.1.2.1. Laser
12.5.3.1.2.2. Non-Laser
12.5.3.2. Spain
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
12.5.3.2.1. Cancer
12.5.3.2.1.1. Lung
12.5.3.2.1.2. Esophagus
12.5.3.2.1.3. Bile
Duct
12.5.3.2.1.4. Bladder
12.5.3.2.1.5. Brain
12.5.3.2.1.6. Ovarian
12.5.3.2.1.7. Others
12.5.3.2.2. Psoriasis
12.5.3.2.3. Acne
12.5.3.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
12.5.3.2.5. Others
12.5.3.3. Spain
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
12.5.3.3.1. Hospitals
12.5.3.3.2. Cancer Treatment Centers
12.5.3.3.3. Skin Clinics
12.5.3.3.4. Others
12.5.4. Germany
12.5.4.1. Germany
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.4.1.1. Drugs
12.5.4.1.1.1. Porfimer
Sodium
12.5.4.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
12.5.4.1.1.3. Aminolevulinic
Acid (ALA)
12.5.4.1.1.4. Others
12.5.4.1.2. Devices
12.5.4.1.2.1. Laser
12.5.4.1.2.2. Non-Laser
12.5.4.2. Germany
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
12.5.4.2.1. Cancer
12.5.4.2.1.1. Lung
12.5.4.2.1.2. Esophagus
12.5.4.2.1.3. Bile
Duct
12.5.4.2.1.4. Bladder
12.5.4.2.1.5. Brain
12.5.4.2.1.6. Ovarian
12.5.4.2.1.7. Others
12.5.4.2.2. Psoriasis
12.5.4.2.3. Acne
12.5.4.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
12.5.4.2.5. Others
12.5.4.3. Germany
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
12.5.4.3.1. Hospitals
12.5.4.3.2. Cancer Treatment Centers
12.5.4.3.3. Skin Clinics
12.5.4.3.4. Others
12.5.5. Italy
12.5.5.1. Italy
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.5.1.1. Drugs
12.5.5.1.1.1. Porfimer
Sodium
12.5.5.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
12.5.5.1.1.3. Aminolevulinic
Acid (ALA)
12.5.5.1.1.4. Others
12.5.5.1.2. Devices
12.5.5.1.2.1. Laser
12.5.5.1.2.2. Non-Laser
12.5.5.2. Italy
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
12.5.5.2.1. Cancer
12.5.5.2.1.1. Lung
12.5.5.2.1.2. Esophagus
12.5.5.2.1.3. Bile
Duct
12.5.5.2.1.4. Bladder
12.5.5.2.1.5. Brain
12.5.5.2.1.6. Ovarian
12.5.5.2.1.7. Others
12.5.5.2.2. Psoriasis
12.5.5.2.3. Acne
12.5.5.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
12.5.5.2.5. Others
12.5.5.3. Italy
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
12.5.5.3.1. Hospitals
12.5.5.3.2. Cancer Treatment Centers
12.5.5.3.3. Skin Clinics
12.5.5.3.4. Others
12.5.6. Nordic
Countries
12.5.6.1. Nordic
Countries Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Offering
12.5.6.1.1. Drugs
12.5.6.1.1.1. Porfimer
Sodium
12.5.6.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
12.5.6.1.1.3. Aminolevulinic
Acid (ALA)
12.5.6.1.1.4. Others
12.5.6.1.2. Devices
12.5.6.1.2.1. Laser
12.5.6.1.2.2. Non-Laser
12.5.6.2. Nordic
Countries Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
12.5.6.2.1. Cancer
12.5.6.2.1.1. Lung
12.5.6.2.1.2. Esophagus
12.5.6.2.1.3. Bile
Duct
12.5.6.2.1.4. Bladder
12.5.6.2.1.5. Brain
12.5.6.2.1.6. Ovarian
12.5.6.2.1.7. Others
12.5.6.2.2. Psoriasis
12.5.6.2.3. Acne
12.5.6.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
12.5.6.2.5. Others
12.5.6.3. Nordic
Countries Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
End-Users
12.5.6.3.1. Hospitals
12.5.6.3.2. Cancer Treatment Centers
12.5.6.3.3. Skin Clinics
12.5.6.3.4. Others
12.5.6.4. Nordic
Countries Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux
Union Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.7.1.1. Drugs
12.5.7.1.1.1. Porfimer
Sodium
12.5.7.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
12.5.7.1.1.3. Aminolevulinic
Acid (ALA)
12.5.7.1.1.4. Others
12.5.7.1.2. Devices
12.5.7.1.2.1. Laser
12.5.7.1.2.2. Non-Laser
12.5.7.2. Benelux
Union Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
12.5.7.2.1. Cancer
12.5.7.2.1.1. Lung
12.5.7.2.1.2. Esophagus
12.5.7.2.1.3. Bile
Duct
12.5.7.2.1.4. Bladder
12.5.7.2.1.5. Brain
12.5.7.2.1.6. Ovarian
12.5.7.2.1.7. Others
12.5.7.2.2. Psoriasis
12.5.7.2.3. Acne
12.5.7.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
12.5.7.2.5. Others
12.5.7.3. Benelux
Union Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
12.5.7.3.1. Hospitals
12.5.7.3.2. Cancer Treatment Centers
12.5.7.3.3. Skin Clinics
12.5.7.3.4. Others
12.5.7.4. Benelux
Union Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest
of Europe Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Offering
12.5.8.1.1. Drugs
12.5.8.1.1.1. Porfimer
Sodium
12.5.8.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
12.5.8.1.1.3. Aminolevulinic
Acid (ALA)
12.5.8.1.1.4. Others
12.5.8.1.2. Devices
12.5.8.1.2.1. Laser
12.5.8.1.2.2. Non-Laser
12.5.8.2. Rest
of Europe Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
12.5.8.2.1. Cancer
12.5.8.2.1.1. Lung
12.5.8.2.1.2. Esophagus
12.5.8.2.1.3. Bile
Duct
12.5.8.2.1.4. Bladder
12.5.8.2.1.5. Brain
12.5.8.2.1.6. Ovarian
12.5.8.2.1.7. Others
12.5.8.2.2. Psoriasis
12.5.8.2.3. Acne
12.5.8.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
12.5.8.2.5. Others
12.5.8.3. Rest
of Europe Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
End-Users
12.5.8.3.1. Hospitals
12.5.8.3.2. Cancer Treatment Centers
12.5.8.3.3. Skin Clinics
12.5.8.3.4. Others
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By
Offering
12.6.3. By
Application
12.6.4. By
End-Users
13. Asia Pacific Photodynamic Therapy Market Analysis and
Forecasts, 2020 - 2028
13.1. Overview
13.1.1. Asia
Pacific Photodynamic Therapy Market Revenue (US$ Mn)
13.2. Asia
Pacific Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
13.2.1. Drugs
13.2.1.1. Porfimer
Sodium
13.2.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
13.2.1.3. Aminolevulinic
Acid (ALA)
13.2.1.4. Others
13.2.2. Devices
13.2.2.1. Laser
13.2.2.2. Non-Laser
13.3. Asia
Pacific Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
13.3.1. Cancer
13.3.1.1. Lung
13.3.1.2. Esophagus
13.3.1.3. Bile
Duct
13.3.1.4. Bladder
13.3.1.5. Brain
13.3.1.6. Ovarian
13.3.1.7. Others
13.3.2. Psoriasis
13.3.3. Acne
13.3.4. Central
Serous Retinopathy/Polypoidal Choroidal Vasculopathy (PCV)
13.3.5. Others
13.4. Asia
Pacific Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
End-Users
13.4.1. Hospitals
13.4.2. Cancer
Treatment Centers
13.4.3. Skin
Clinics
13.4.4. Others
13.5. Asia
Pacific Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.1.1.1. Drugs
13.5.1.1.1.1. Porfimer
Sodium
13.5.1.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
13.5.1.1.1.3. Aminolevulinic
Acid (ALA)
13.5.1.1.1.4. Others
13.5.1.1.2. Devices
13.5.1.1.2.1. Laser
13.5.1.1.2.2. Non-Laser
13.5.1.2. China
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1.2.1. Cancer
13.5.1.2.1.1. Lung
13.5.1.2.1.2. Esophagus
13.5.1.2.1.3. Bile
Duct
13.5.1.2.1.4. Bladder
13.5.1.2.1.5. Brain
13.5.1.2.1.6. Ovarian
13.5.1.2.1.7. Others
13.5.1.2.2. Psoriasis
13.5.1.2.3. Acne
13.5.1.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
13.5.1.2.5. Others
13.5.1.3. China
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
13.5.1.3.1. Hospitals
13.5.1.3.2. Cancer Treatment Centers
13.5.1.3.3. Skin Clinics
13.5.1.3.4. Others
13.5.2. Japan
13.5.2.1. Japan
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.2.1.1. Drugs
13.5.2.1.1.1. Porfimer
Sodium
13.5.2.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
13.5.2.1.1.3. Aminolevulinic
Acid (ALA)
13.5.2.1.1.4. Others
13.5.2.1.2. Devices
13.5.2.1.2.1. Laser
13.5.2.1.2.2. Non-Laser
13.5.2.2. Japan
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
13.5.2.2.1. Cancer
13.5.2.2.1.1. Lung
13.5.2.2.1.2. Esophagus
13.5.2.2.1.3. Bile
Duct
13.5.2.2.1.4. Bladder
13.5.2.2.1.5. Brain
13.5.2.2.1.6. Ovarian
13.5.2.2.1.7. Others
13.5.2.2.2. Psoriasis
13.5.2.2.3. Acne
13.5.2.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
13.5.2.2.5. Others
13.5.2.3. Japan
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
13.5.2.3.1. Hospitals
13.5.2.3.2. Cancer Treatment Centers
13.5.2.3.3. Skin Clinics
13.5.2.3.4. Others
13.5.3. India
13.5.3.1. India
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.3.1.1. Drugs
13.5.3.1.1.1. Porfimer
Sodium
13.5.3.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
13.5.3.1.1.3. Aminolevulinic
Acid (ALA)
13.5.3.1.1.4. Others
13.5.3.1.2. Devices
13.5.3.1.2.1. Laser
13.5.3.1.2.2. Non-Laser
13.5.3.2. India
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
13.5.3.2.1. Cancer
13.5.3.2.1.1. Lung
13.5.3.2.1.2. Esophagus
13.5.3.2.1.3. Bile
Duct
13.5.3.2.1.4. Bladder
13.5.3.2.1.5. Brain
13.5.3.2.1.6. Ovarian
13.5.3.2.1.7. Others
13.5.3.2.2. Psoriasis
13.5.3.2.3. Acne
13.5.3.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
13.5.3.2.5. Others
13.5.3.3. India
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
13.5.3.3.1. Hospitals
13.5.3.3.2. Cancer Treatment Centers
13.5.3.3.3. Skin Clinics
13.5.3.3.4. Others
13.5.4. New
Zealand
13.5.4.1. New
Zealand Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.4.1.1. Drugs
13.5.4.1.1.1. Porfimer
Sodium
13.5.4.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
13.5.4.1.1.3. Aminolevulinic
Acid (ALA)
13.5.4.1.1.4. Others
13.5.4.1.2. Devices
13.5.4.1.2.1. Laser
13.5.4.1.2.2. Non-Laser
13.5.4.2. New
Zealand Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.4.2.1. Cancer
13.5.4.2.1.1. Lung
13.5.4.2.1.2. Esophagus
13.5.4.2.1.3. Bile
Duct
13.5.4.2.1.4. Bladder
13.5.4.2.1.5. Brain
13.5.4.2.1.6. Ovarian
13.5.4.2.1.7. Others
13.5.4.2.2. Psoriasis
13.5.4.2.3. Acne
13.5.4.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
13.5.4.2.5. Others
13.5.4.3. New
Zealand Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
End-Users
13.5.4.3.1. Hospitals
13.5.4.3.2. Cancer Treatment Centers
13.5.4.3.3. Skin Clinics
13.5.4.3.4. Others
13.5.5. Australia
13.5.5.1. Australia
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.5.1.1. Drugs
13.5.5.1.1.1. Porfimer
Sodium
13.5.5.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
13.5.5.1.1.3. Aminolevulinic
Acid (ALA)
13.5.5.1.1.4. Others
13.5.5.1.2. Devices
13.5.5.1.2.1. Laser
13.5.5.1.2.2. Non-Laser
13.5.5.2. Australia
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
13.5.5.2.1. Cancer
13.5.5.2.1.1. Lung
13.5.5.2.1.2. Esophagus
13.5.5.2.1.3. Bile
Duct
13.5.5.2.1.4. Bladder
13.5.5.2.1.5. Brain
13.5.5.2.1.6. Ovarian
13.5.5.2.1.7. Others
13.5.5.2.2. Psoriasis
13.5.5.2.3. Acne
13.5.5.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
13.5.5.2.5. Others
13.5.5.3. Australia
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
13.5.5.3.1. Hospitals
13.5.5.3.2. Cancer Treatment Centers
13.5.5.3.3. Skin Clinics
13.5.5.3.4. Others
13.5.6. South
Korea
13.5.6.1. South
Korea Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.6.1.1. Drugs
13.5.6.1.1.1. Porfimer
Sodium
13.5.6.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
13.5.6.1.1.3. Aminolevulinic
Acid (ALA)
13.5.6.1.1.4. Others
13.5.6.1.2. Devices
13.5.6.1.2.1. Laser
13.5.6.1.2.2. Non-Laser
13.5.6.2. South
Korea Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.6.2.1. Cancer
13.5.6.2.1.1. Lung
13.5.6.2.1.2. Esophagus
13.5.6.2.1.3. Bile
Duct
13.5.6.2.1.4. Bladder
13.5.6.2.1.5. Brain
13.5.6.2.1.6. Ovarian
13.5.6.2.1.7. Others
13.5.6.2.2. Psoriasis
13.5.6.2.3. Acne
13.5.6.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
13.5.6.2.5. Others
13.5.6.3. South
Korea Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
13.5.6.3.1. Hospitals
13.5.6.3.2. Cancer Treatment Centers
13.5.6.3.3. Skin Clinics
13.5.6.3.4. Others
13.5.7. Southeast
Asia
13.5.7.1. Southeast
Asia Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.7.1.1. Drugs
13.5.7.1.1.1. Porfimer
Sodium
13.5.7.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
13.5.7.1.1.3. Aminolevulinic
Acid (ALA)
13.5.7.1.1.4. Others
13.5.7.1.2. Devices
13.5.7.1.2.1. Laser
13.5.7.1.2.2. Non-Laser
13.5.7.2. Southeast
Asia Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
13.5.7.2.1. Cancer
13.5.7.2.1.1. Lung
13.5.7.2.1.2. Esophagus
13.5.7.2.1.3. Bile
Duct
13.5.7.2.1.4. Bladder
13.5.7.2.1.5. Brain
13.5.7.2.1.6. Ovarian
13.5.7.2.1.7. Others
13.5.7.2.2. Psoriasis
13.5.7.2.3. Acne
13.5.7.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
13.5.7.2.5. Others
13.5.7.3. Southeast
Asia Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
13.5.7.3.1. Hospitals
13.5.7.3.2. Cancer Treatment Centers
13.5.7.3.3. Skin Clinics
13.5.7.3.4. Others
13.5.7.4. Southeast
Asia Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest
of Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Offering
13.5.8.1.1. Drugs
13.5.8.1.1.1. Porfimer
Sodium
13.5.8.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
13.5.8.1.1.3. Aminolevulinic
Acid (ALA)
13.5.8.1.1.4. Others
13.5.8.1.2. Devices
13.5.8.1.2.1. Laser
13.5.8.1.2.2. Non-Laser
13.5.8.2. Rest
of Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.8.2.1. Cancer
13.5.8.2.1.1. Lung
13.5.8.2.1.2. Esophagus
13.5.8.2.1.3. Bile
Duct
13.5.8.2.1.4. Bladder
13.5.8.2.1.5. Brain
13.5.8.2.1.6. Ovarian
13.5.8.2.1.7. Others
13.5.8.2.2. Psoriasis
13.5.8.2.3. Acne
13.5.8.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
13.5.8.2.5. Others
13.5.8.3. Rest
of Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
End-Users
13.5.8.3.1. Hospitals
13.5.8.3.2. Cancer Treatment Centers
13.5.8.3.3. Skin Clinics
13.5.8.3.4. Others
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Offering
13.6.3. By
Application
13.6.4. By
End-Users
14. Middle East and Africa Photodynamic Therapy Market Analysis
and Forecasts, 2020 - 2028
14.1. Overview
14.1.1. Middle
East and Africa Photodynamic Therapy Market Revenue (US$ Mn)
14.2. Middle
East and Africa Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Offering
14.2.1. Drugs
14.2.1.1. Porfimer
Sodium
14.2.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
14.2.1.3. Aminolevulinic
Acid (ALA)
14.2.1.4. Others
14.2.2. Devices
14.2.2.1. Laser
14.2.2.2. Non-Laser
14.3. Middle
East and Africa Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
14.3.1. Cancer
14.3.1.1. Lung
14.3.1.2. Esophagus
14.3.1.3. Bile
Duct
14.3.1.4. Bladder
14.3.1.5. Brain
14.3.1.6. Ovarian
14.3.1.7. Others
14.3.2. Psoriasis
14.3.3. Acne
14.3.4. Central
Serous Retinopathy/Polypoidal Choroidal Vasculopathy (PCV)
14.3.5. Others
14.4. Middle
East and Africa Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
End-Users
14.4.1. Hospitals
14.4.2. Cancer
Treatment Centers
14.4.3. Skin
Clinics
14.4.4. Others
14.5. Middle
East and Africa Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi
Arabia Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.1.1.1. Drugs
14.5.1.1.1.1. Porfimer
Sodium
14.5.1.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
14.5.1.1.1.3. Aminolevulinic
Acid (ALA)
14.5.1.1.1.4. Others
14.5.1.1.2. Devices
14.5.1.1.2.1. Laser
14.5.1.1.2.2. Non-Laser
14.5.1.2. Saudi
Arabia Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
14.5.1.2.1. Cancer
14.5.1.2.1.1. Lung
14.5.1.2.1.2. Esophagus
14.5.1.2.1.3. Bile
Duct
14.5.1.2.1.4. Bladder
14.5.1.2.1.5. Brain
14.5.1.2.1.6. Ovarian
14.5.1.2.1.7. Others
14.5.1.2.2. Psoriasis
14.5.1.2.3. Acne
14.5.1.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
14.5.1.2.5. Others
14.5.1.3. Saudi
Arabia Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
14.5.1.3.1. Hospitals
14.5.1.3.2. Cancer Treatment Centers
14.5.1.3.3. Skin Clinics
14.5.1.3.4. Others
14.5.2. UAE
14.5.2.1. UAE
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.2.1.1. Drugs
14.5.2.1.1.1. Porfimer
Sodium
14.5.2.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
14.5.2.1.1.3. Aminolevulinic
Acid (ALA)
14.5.2.1.1.4. Others
14.5.2.1.2. Devices
14.5.2.1.2.1. Laser
14.5.2.1.2.2. Non-Laser
14.5.2.2. UAE
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
14.5.2.2.1. Cancer
14.5.2.2.1.1. Lung
14.5.2.2.1.2. Esophagus
14.5.2.2.1.3. Bile
Duct
14.5.2.2.1.4. Bladder
14.5.2.2.1.5. Brain
14.5.2.2.1.6. Ovarian
14.5.2.2.1.7. Others
14.5.2.2.2. Psoriasis
14.5.2.2.3. Acne
14.5.2.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
14.5.2.2.5. Others
14.5.2.3. UAE
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
14.5.2.3.1. Hospitals
14.5.2.3.2. Cancer Treatment Centers
14.5.2.3.3. Skin Clinics
14.5.2.3.4. Others
14.5.3. Egypt
14.5.3.1. Egypt
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.3.1.1. Drugs
14.5.3.1.1.1. Porfimer
Sodium
14.5.3.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
14.5.3.1.1.3. Aminolevulinic
Acid (ALA)
14.5.3.1.1.4. Others
14.5.3.1.2. Devices
14.5.3.1.2.1. Laser
14.5.3.1.2.2. Non-Laser
14.5.3.2. Egypt
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
14.5.3.2.1. Cancer
14.5.3.2.1.1. Lung
14.5.3.2.1.2. Esophagus
14.5.3.2.1.3. Bile
Duct
14.5.3.2.1.4. Bladder
14.5.3.2.1.5. Brain
14.5.3.2.1.6. Ovarian
14.5.3.2.1.7. Others
14.5.3.2.2. Psoriasis
14.5.3.2.3. Acne
14.5.3.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
14.5.3.2.5. Others
14.5.3.3. Egypt
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
14.5.3.3.1. Hospitals
14.5.3.3.2. Cancer Treatment Centers
14.5.3.3.3. Skin Clinics
14.5.3.3.4. Others
14.5.4. Kuwait
14.5.4.1. Kuwait
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.4.1.1. Drugs
14.5.4.1.1.1. Porfimer
Sodium
14.5.4.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
14.5.4.1.1.3. Aminolevulinic
Acid (ALA)
14.5.4.1.1.4. Others
14.5.4.1.2. Devices
14.5.4.1.2.1. Laser
14.5.4.1.2.2. Non-Laser
14.5.4.2. Kuwait
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
14.5.4.2.1. Cancer
14.5.4.2.1.1. Lung
14.5.4.2.1.2. Esophagus
14.5.4.2.1.3. Bile
Duct
14.5.4.2.1.4. Bladder
14.5.4.2.1.5. Brain
14.5.4.2.1.6. Ovarian
14.5.4.2.1.7. Others
14.5.4.2.2. Psoriasis
14.5.4.2.3. Acne
14.5.4.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
14.5.4.2.5. Others
14.5.4.3. Kuwait
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
14.5.4.3.1. Hospitals
14.5.4.3.2. Cancer Treatment Centers
14.5.4.3.3. Skin Clinics
14.5.4.3.4. Others
14.5.5. South
Africa
14.5.5.1. South
Africa Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.5.1.1. Drugs
14.5.5.1.1.1. Porfimer
Sodium
14.5.5.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
14.5.5.1.1.3. Aminolevulinic
Acid (ALA)
14.5.5.1.1.4. Others
14.5.5.1.2. Devices
14.5.5.1.2.1. Laser
14.5.5.1.2.2. Non-Laser
14.5.5.2. South
Africa Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
14.5.5.2.1. Cancer
14.5.5.2.1.1. Lung
14.5.5.2.1.2. Esophagus
14.5.5.2.1.3. Bile
Duct
14.5.5.2.1.4. Bladder
14.5.5.2.1.5. Brain
14.5.5.2.1.6. Ovarian
14.5.5.2.1.7. Others
14.5.5.2.2. Psoriasis
14.5.5.2.3. Acne
14.5.5.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
14.5.5.2.5. Others
14.5.5.3. South
Africa Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
14.5.5.3.1. Hospitals
14.5.5.3.2. Cancer Treatment Centers
14.5.5.3.3. Skin Clinics
14.5.5.3.4. Others
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest
of Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) and
Forecasts, By Offering
14.5.6.1.1. Drugs
14.5.6.1.1.1. Porfimer
Sodium
14.5.6.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
14.5.6.1.1.3. Aminolevulinic
Acid (ALA)
14.5.6.1.1.4. Others
14.5.6.1.2. Devices
14.5.6.1.2.1. Laser
14.5.6.1.2.2. Non-Laser
14.5.6.2. Rest
of Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.6.2.1. Cancer
14.5.6.2.1.1. Lung
14.5.6.2.1.2. Esophagus
14.5.6.2.1.3. Bile
Duct
14.5.6.2.1.4. Bladder
14.5.6.2.1.5. Brain
14.5.6.2.1.6. Ovarian
14.5.6.2.1.7. Others
14.5.6.2.2. Psoriasis
14.5.6.2.3. Acne
14.5.6.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
14.5.6.2.5. Others
14.5.6.3. Rest
of Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) and
Forecasts, By End-Users
14.5.6.3.1. Hospitals
14.5.6.3.2. Cancer Treatment Centers
14.5.6.3.3. Skin Clinics
14.5.6.3.4. Others
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Offering
14.6.3. By
Application
14.6.4. By
End-Users
15. Latin America Photodynamic Therapy Market Analysis and
Forecasts, 2020 - 2028
15.1. Overview
15.1.1. Latin
America Photodynamic Therapy Market Revenue (US$ Mn)
15.2. Latin
America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
15.2.1. Drugs
15.2.1.1. Porfimer
Sodium
15.2.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
15.2.1.3. Aminolevulinic
Acid (ALA)
15.2.1.4. Others
15.2.2. Devices
15.2.2.1. Laser
15.2.2.2. Non-Laser
15.3. Latin
America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
15.3.1. Cancer
15.3.1.1. Lung
15.3.1.2. Esophagus
15.3.1.3. Bile
Duct
15.3.1.4. Bladder
15.3.1.5. Brain
15.3.1.6. Ovarian
15.3.1.7. Others
15.3.2. Psoriasis
15.3.3. Acne
15.3.4. Central
Serous Retinopathy/Polypoidal Choroidal Vasculopathy (PCV)
15.3.5. Others
15.4. Latin
America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
End-Users
15.4.1. Hospitals
15.4.2. Cancer
Treatment Centers
15.4.3. Skin
Clinics
15.4.4. Others
15.5. Latin
America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
15.5.1.1.1. Drugs
15.5.1.1.1.1. Porfimer
Sodium
15.5.1.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
15.5.1.1.1.3. Aminolevulinic
Acid (ALA)
15.5.1.1.1.4. Others
15.5.1.1.2. Devices
15.5.1.1.2.1. Laser
15.5.1.1.2.2. Non-Laser
15.5.1.2. Brazil
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
15.5.1.2.1. Cancer
15.5.1.2.1.1. Lung
15.5.1.2.1.2. Esophagus
15.5.1.2.1.3. Bile
Duct
15.5.1.2.1.4. Bladder
15.5.1.2.1.5. Brain
15.5.1.2.1.6. Ovarian
15.5.1.2.1.7. Others
15.5.1.2.2. Psoriasis
15.5.1.2.3. Acne
15.5.1.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
15.5.1.2.5. Others
15.5.1.3. Brazil
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
15.5.1.3.1. Hospitals
15.5.1.3.2. Cancer Treatment Centers
15.5.1.3.3. Skin Clinics
15.5.1.3.4. Others
15.5.2. Argentina
15.5.2.1. Argentina
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
15.5.2.1.1. Drugs
15.5.2.1.1.1. Porfimer
Sodium
15.5.2.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
15.5.2.1.1.3. Aminolevulinic
Acid (ALA)
15.5.2.1.1.4. Others
15.5.2.1.2. Devices
15.5.2.1.2.1. Laser
15.5.2.1.2.2. Non-Laser
15.5.2.2. Argentina
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By Application
15.5.2.2.1. Cancer
15.5.2.2.1.1. Lung
15.5.2.2.1.2. Esophagus
15.5.2.2.1.3. Bile
Duct
15.5.2.2.1.4. Bladder
15.5.2.2.1.5. Brain
15.5.2.2.1.6. Ovarian
15.5.2.2.1.7. Others
15.5.2.2.2. Psoriasis
15.5.2.2.3. Acne
15.5.2.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
15.5.2.2.5. Others
15.5.2.3. Argentina
Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By End-Users
15.5.2.3.1. Hospitals
15.5.2.3.2. Cancer Treatment Centers
15.5.2.3.3. Skin Clinics
15.5.2.3.4. Others
15.5.3. Rest of
Latin America
15.5.3.1. Rest
of Latin America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Offering
15.5.3.1.1. Drugs
15.5.3.1.1.1. Porfimer
Sodium
15.5.3.1.1.2. Methyl
Ester of Aminolevulinic Acid (ALA)
15.5.3.1.1.3. Aminolevulinic
Acid (ALA)
15.5.3.1.1.4. Others
15.5.3.1.2. Devices
15.5.3.1.2.1. Laser
15.5.3.1.2.2. Non-Laser
15.5.3.2. Rest
of Latin America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
15.5.3.2.1. Cancer
15.5.3.2.1.1. Lung
15.5.3.2.1.2. Esophagus
15.5.3.2.1.3. Bile
Duct
15.5.3.2.1.4. Bladder
15.5.3.2.1.5. Brain
15.5.3.2.1.6. Ovarian
15.5.3.2.1.7. Others
15.5.3.2.2. Psoriasis
15.5.3.2.3. Acne
15.5.3.2.4. Central Serous Retinopathy/Polypoidal Choroidal Vasculopathy
(PCV)
15.5.3.2.5. Others
15.5.3.3. Rest
of Latin America Photodynamic Therapy Market Revenue (US$ Mn) and Forecasts, By
End-Users
15.5.3.3.1. Hospitals
15.5.3.3.2. Cancer Treatment Centers
15.5.3.3.3. Skin Clinics
15.5.3.3.4. Others
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Offering
15.6.3. By
Application
15.6.4. By
End-Users
16. Competitive Benchmarking
16.1. Market
Share Analysis, 2019
16.2. Global
Presence and Growth Strategies
16.2.1. Mergers
and Acquisitions
16.2.2. Product
Launches
16.2.3. Investments
Trends
16.2.4. R&D
Initiatives
17. Player Profiles
17.1. Bausch
& Lomb
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. Biofrontera
Inc.
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business
Strategies
17.3. biolitec
AG
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business
Strategies
17.4. Galderma
Nordic AB
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. MODULIGHT
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. Quantel
Medical
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business
Strategies
17.7. Quest
PharmaTech Inc
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business
Strategies
17.8. Soligeneix
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT
Analysis
17.8.7. Business
Strategies
17.9. Sun
Pharma
17.9.1. Company
Details
17.9.2. Company
Overview
17.9.3. Product
Offerings
17.9.4. Key
Developments
17.9.5. Financial
Analysis
17.9.6. SWOT
Analysis
17.9.7. Business
Strategies
17.10. Theralase
Technologies Inc.
17.10.1. Company
Details
17.10.2. Company
Overview
17.10.3. Product
Offerings
17.10.4. Key
Developments
17.10.5. Financial
Analysis
17.10.6. SWOT
Analysis
17.10.7. Business
Strategies
17.11. Other
Market Participants
18.
Key skills:
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
